Age-period-cohort analysis of trends in amyotrophic lateral sclerosis in Denmark, 1970-2009

American Journal of Epidemiology

Volumn 178, Issue 8, 2013, Pages 1265-1271

  Seals, Ryan M ^a   Hansen, Johnni ^a   Gredal, Ole ^a   Weisskopf, Marc G ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

age period cohort model; amyotrophic lateral sclerosis; brain disorders; neurodegenerative disorders; neuroepidemiology

Indexed keywords

COHORT ANALYSIS; DATA ACQUISITION; DISEASE INCIDENCE; ETIOLOGY; MORTALITY; NEUROLOGY; NUMERICAL MODEL; PARAMETERIZATION;

ADULT; AGE DISTRIBUTION; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BIRTH; COHORT ANALYSIS; DEATH; DENMARK; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; SEX RATIO;

AGE-PERIOD-COHORT MODEL; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN DISORDERS; NEURODEGENERATIVE DISORDERS; NEUROEPIDEMIOLOGY;

AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; COHORT STUDIES; DENMARK; HUMANS; MIDDLE AGED;

DENMARK;

EID: 84885781946     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwt116     Document Type: Article

References (27)

1. Sejvar JJ, Holman RC, Bresee JS, et al. Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. Neuroepidemiology. 2005;25(3):144-152. (Pubitemid 41207067)
2. Fang F, Valdimarsdóttir U, Bellocco R, et al. Amyotrophic lateral sclerosis in Sweden, 1991-2005. Arch Neurol. 2009; 66(4):515-519.
3. Seljeseth YM, Vollset SE, Tysnes OB. Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology. 2000;55(9):1262-1266.
4. Ajdacic-Gross V, SchmidM, Tschopp A, et al. Birth cohort effects in neurological diseases: amyotrophic lateral sclerosis, Parkinson's disease and multiple sclerosis. Neuroepidemiology. 2012;38(1):56-63.
5. Gordon PH, Artaud F, Aouba A, et al. Changing mortality for motor neuron disease in France (1968-2007): an age-periodcohort analysis. Eur J Epidemiol. 2011;26(9):729-737.
6. Clayton D, Schifflers E. Models for temporal variation in cancer rates. I: Age-period and age-cohort models. Stat Med. 1987;6(4):449-467. (Pubitemid 17110908)
7. Alonso A, Logroscino G, Hernan MA. Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and metaanalysis. J Neurol Neurosurg Psychiatry. 2010;81(11): 1249-1252.
8. Clayton D, Schifflers E. Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med. 1987; 6(4):469-481. (Pubitemid 17110909)
9. Holford TR. Analysing the temporal effects of age, period and cohort. Stat Methods Med Res. 1992;1(3):317-337.
10. Holford TR. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health. 1991;12(1):425-457.
11. Helweg-Larsen K. The Danish Register of Causes of Death. Scand J Public Health. 2011;39(7 suppl):26-29.
12. Marin B, Couratier P, Preux P-M, et al. Can mortality data be used to estimate amyotrophic lateral sclerosis incidence? Neuroepidemiology. 2011;36(1):29-38.
13. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011; 39(7 suppl):30-33.
14. Pedersen CB, Gøtzsche H, Møller JO, et al. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006;53(4):441-449. (Pubitemid 44816920)
15. Carstensen B. Age-period-cohort models for the Lexis diagram. Stat Med. 2007;26(15):3018-3045. (Pubitemid 46939424)
16. Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet. 2007;369(9578):2031-2041.
17. Scarmeas N, Shih T, Stern Y, et al. Premorbid weight, body mass, and varsity athletics in ALS. Neurology. 2002; 59(5):773-775.
18. Veldink JH, Kalmijn S, Groeneveld GJ, et al. Physical activity and the association with sporadic ALS. Neurology. 2005; 64(2):241-245.
19. Savica R, Parisi JE,Wold LE, et al. High school football and risk of neurodegeneration: a community-based study. Mayo Clin Proc. 2012;87(4):335-340.
20. Vivekananda U, Manjalay Z-R, Ganesalingam J, et al. Low index-to-ring finger length ratio in sporadic ALS supports prenatally defined motor neuronal vulnerability. J Neurol Neurosurg Psychiatr. 2011;82(6):635-637.
21. Weisskopf MG, Morozova N, O'Reilly EJ, et al. Prospective study of chemical exposures and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatr. 2009;80(5):558-561.
22. Weisskopf MG, O'Reilly EJ, McCullough ML, et al. Prospective study of military service and mortality from ALS. Neurology. 2005;64(1):32-37. (Pubitemid 40082933)
23. Andersen TF, Madsen M, Jørgensen J, et al. The Danish National Hospital Register. Avaluable source of data for modern health sciences. Dan Med Bull. 1999;46(3):263-268. (Pubitemid 29299976)
24. Beghi E, Logroscino G, Micheli A, et al. Validity of hospital discharge diagnoses for the assessment of the prevalence and incidence of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001; 2(2):99-104. (Pubitemid 32904385)
25. Pisa FE, Verriello L, Deroma L, et al. The accuracy of discharge diagnosis coding for amyotrophic lateral sclerosis in a large teaching hospital. Eur J Epidemiol. 2009;24(10): 635-640.
26. Chancellor AM, Swingler RJ, Fraser H, et al. Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease. J Epidemiol Community Health. 1993;47(2):116-120. (Pubitemid 23135950)
27. Johansen C. Exposure to electromagnetic fields and risk of central nervous system disease in utility workers. Epidemiology. 2000;11(5):539-543. (Pubitemid 30660032)